Does Cymbalta (duloxetine) cause hypotension or bradycardia?

Cymbalta Does NOT Typically Cause Low Blood Pressure or Low Heart Rate

Cymbalta (duloxetine) is more likely to cause orthostatic hypotension (a drop in blood pressure upon standing) rather than sustained low blood pressure, and it typically increases heart rate rather than causing bradycardia. 1

Cardiovascular Effects of Duloxetine

Blood Pressure Effects

The FDA label explicitly warns about orthostatic hypotension and syncope as recognized adverse effects 1. However, this is distinct from sustained hypotension:

• Orthostatic hypotension (positional drop in BP) occurs in approximately 15-20% of patients 2
• Duloxetine does not produce clinically important blood pressure changes in most patients 3
• The drug actually requires monitoring for blood pressure elevation, not reduction, as hypertension is a more common concern 1
• Meta-analysis data shows duloxetine increases diastolic blood pressure by 0.82 mmHg on average 4

Heart Rate Effects

Duloxetine increases heart rate, not decreases it:

• Meta-analysis demonstrates an average heart rate increase of 2.22 beats per minute 4
• Tachycardia (elevated heart rate) is a recognized adverse effect, occurring in up to 48% of overdose cases 5
• Bradycardia is not listed as a warning or common adverse effect in FDA labeling 1

Clinical Context: Sympathomimetic Properties

Duloxetine's mechanism as a serotonin-norepinephrine reuptake inhibitor means it enhances noradrenergic activity, which typically produces:

• Increased heart rate (tachycardia)
• Mild hypertension (45% in overdose studies) 5
• Sympathomimetic effects 5

This pharmacologic profile is opposite to what would cause sustained hypotension or bradycardia.

Important Caveats

When Hypotension Can Occur:

1. Orthostatic changes: Standing up quickly may cause dizziness and BP drops 1, 2
2. Drug interactions: When combined with beta-blockers, duloxetine (as a CYP2D6 inhibitor) can increase beta-blocker levels, potentially leading to hypotension and bradycardia 6
3. Elderly patients: More susceptible to orthostatic effects, though studies show similar rates to placebo (15.6% vs 20.5%) 2
4. Overdose with co-ingestants: Hypotension occurred in 8% when other medications were involved 5

Monitoring Recommendations:

• Check blood pressure before starting and periodically during treatment 1
• Monitor for orthostatic symptoms (dizziness upon standing) rather than sustained hypotension
• Be cautious when combining with beta-blockers or other medications affecting heart rate/BP 6

Bottom Line

The concern should be orthostatic hypotension (positional BP changes) and potential heart rate increases, not sustained low blood pressure or bradycardia. The FDA requires monitoring for blood pressure elevation, not reduction 1. Duloxetine's cardiovascular safety profile shows it does not produce clinically significant sustained hypotension or bradycardia in therapeutic use 7.